SELLAS Life Sciences (SLS) Non Operating Income (2012 - 2026)
SELLAS Life Sciences' Non Operating Income came in at $1.02 million for Q2 2026, up 276.5% from $272,000 a year earlier and up 21.2% from the prior quarter.
SELLAS Life Sciences (SLS) Non Operating Income (2012 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, SELLAS Life Sciences reported Non Operating Income of $2.76 million, up 198.5% year-over-year; for FY2025, it was $1.41 million, up 123.3% from FY2024.
- Non Operating Income carries a five-year compound annual growth rate of 46.7% (FY2020 to FY2025).
- Going back by year, Non Operating Income was $632,000 in FY2024 (+19.5%), $529,000 in FY2023 (-18.5%), $649,000 in FY2022 (-85.1%) and $4.36 million in FY2021.
- The Q2 2026 figure represents the highest quarterly Non Operating Income since Q4 2014.
- Year-over-year, Non Operating Income has increased for eight consecutive quarters, with growth averaging 193.7% over the last eight quarters.
- The fastest year-over-year change in Non Operating Income over five years came in Q4 2024 (growth of 341.5%), and the weakest in Q4 2023 (a decline of 87.4%).
- Business Quant data shows SLS's Non Operating Income at $845,000 (Q1 2026), $597,000 (Q4 2025) and $292,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | SELLAS Life Sciences | 2.49 Bn | 2.49 Bn | - | 1.02 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.02 Mn |
| Mar 31, 2026 | 845,000.00 |
| Dec 31, 2025 | 597,000.00 |
| Sep 30, 2025 | 292,000.00 |
| Jun 30, 2025 | 272,000.00 |
| Mar 31, 2025 | 250,000.00 |
| Dec 31, 2024 | 181,000.00 |
| Sep 30, 2024 | 221,000.00 |
| Jun 30, 2024 | 151,000.00 |
| Mar 31, 2024 | 79,000.00 |
| Dec 31, 2023 | 41,000.00 |
| Sep 30, 2023 | 94,000.00 |
| Jun 30, 2023 | 210,000.00 |
| Mar 31, 2023 | 184,000.00 |
| Dec 31, 2022 | 325,000.00 |
| Sep 30, 2022 | 124,000.00 |
| Jun 30, 2022 | 209,000.00 |
| Dec 31, 2019 | -7.50 Mn |
| Sep 30, 2019 | -4.20 Mn |
| Jun 30, 2019 | -3.13 Mn |
SELLAS Life Sciences Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=SLS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "SLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=SLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();